The accumulation of additional mutations in p53 (TP53), transforming growth factor-β (TGF-β; SMAD4, TGFBR2), and PI3K/AKT (PIK3CA, PTEN) signaling pathways are required for progression to carcinoma. This evidence concerns the gene TP53 and carcinoma.